Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs State Street Corporation Common Stock (STT) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade
State Street Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs State Street Corporation Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.45 (market cap $12.58B), while State Street Corporation Common Stock trades at $175.29 (market cap $48.10B). The key difference: State Street Corporation Common Stock is far larger — about 3.8× Halozyme Therapeutics Inc. Common Stock's market cap, and State Street Corporation Common Stock pays a 2.1% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and State Street Corporation Common Stock for 0 Days on average.

HALOSTT
Market Cap
$12.58B$48.10B
Volume
2,179,2782,033,865
Sector
HealthFinancials
52-Week High
$115.22$194.26
52-Week Low
$61.63$111.00
Typical Hold Time
0 Days0 Days
Enterprise Value
$14.49B$74.64B
Dividend Yield
—2.1%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HALO
100% Buy0% Sell
Avg holding period · 0 Days
STT
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About State Street Corporation Common Stock

State Street provides investment servicing, custody, and asset management services to institutional investors. Its asset management business includes the SPDR ETF range.

Read more on STT →